Could less treatment be just as effective for advanced bladder cancer?
NCT ID NCT05923190
Summary
This study is testing whether giving an existing bladder cancer drug less frequently can still control the disease while potentially reducing side effects. The trial involves 60 adults with advanced bladder cancer who would normally receive standard treatment. Researchers want to see if spacing out the drug doses maintains the same benefits while improving patients' quality of life.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for METASTATIC UROTHELIAL CARCINOMA are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Fox Chase Cancer Center - Philadelphia
Philadelphia, Pennsylvania, 19111-2497, United States
Conditions
Explore the condition pages connected to this study.